Pharma News, 2020

People who develop Parkinson's disease before age 50 may have been born with disordered brain cells that went undetected for decades, according to new Cedars-Sinai research.

Innovativeness and a commitment to social responsibility are just some of the respected attributes that helped the company land on the prestigious list for another year.

Fentanyl use by people who use drugs has doubled since 2015, and two-thirds of people are aware they've taken it, finds new research out of British Columbia, the Canadian province that has experie...

CAMBRIDGE, Mass.

NEW YORK (Reuters) - A group of Blue Cross Blue Shield insurers is investing $55 million in a venture that aims to offer cheaper prices to their members on generic drugs that currently have li...

A group of University of Chicago scientists has uncovered a previously unknown way that our genes are made into reality.

In the past several weeks, a biting joke has been widely shared on Chinese social media.

2019 ended on a high note for Alzheimer’s research.

As Gilead gears up to launch filgotinib, the JAK inhibitor it has under FDA review in rheumatoid arthritis, it knows full well it’s prepping for entry into a crowded market.

Horizon Therapeutics is trying to shed its reputation as a primary care drugmaker and emerge with a brand-new life in rare diseases.

As fears about the spread of a new coronavirus grip communities ranging from Washington State in the U.

Scientists have been testing various ways to tackle neurodegenerative diseases—blocking the production of toxic proteins, regenerating functional neurons and restoring the brain’s waste-clearing s...